Please provide your email address to receive an email when new articles are posted on . The FDA has approved multiple first generics of Vyvanse capsules and chewable tablets for ADHD in patients aged ...
Credit: Getty Images. Lisdexamfetamine dimesylate capsules and chewable tablets are indicated for ADHD in patients aged 6 years and older, and for moderate to severe binge-eating disorder in adults.
In response to the ongoing shortage of ADHD medications, the U.S. Food and Drug Administration (FDA) has approved several generic versions of Vyvanse ...
Fox News: Generic versions of Vyvanse released to address ADHD medicine shortage in US
Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical's drug Vyvanse, which is expected to offset the ongoing shortage of the ADHD medicine in the United States. The U.S. Food and ...
Generic versions of Vyvanse released to address ADHD medicine shortage in US
Aug 31 (Reuters) - Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical's (4502.T), opens new tab drug Vyvanse, which is expected to offset the ongoing shortage of the ADHD ...
MSN: ADHD Med Recall 2025: Another Batch of Generic Vyvanse Fails Tests